PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Exenatide
Presentation Product Chemical substance Chapter Items dispensed
Bydureon BCise 2mg/0.85ml prolonged-release inj pf pens
0601023Y0BCACAE
Bydureon Exenatide Endocrine System 6,424
Exenatide 10micrograms/0.04ml inj 2.4ml pf dispos dev
0601023Y0AAABAB
Exenatide Exenatide Endocrine System 3,263
Exenatide 2mg/0.85ml prolonged-release inj pf dispos dev
0601023Y0AAAEAE
Exenatide Exenatide Endocrine System 3,030
Bydureon 2mg inj pre-filled pens
0601023Y0BCABAD
Bydureon Exenatide Endocrine System 2,170
Exenatide 2mg inj pre-filled disposable devices
0601023Y0AAADAD
Exenatide Exenatide Endocrine System 1,898
Exenatide 5micrograms/0.02ml inj 1.2ml pf dispos dev
0601023Y0AAAAAA
Exenatide Exenatide Endocrine System 752
Byetta 10micrograms/0.04ml inj 2.4ml pre-filled pens
0601023Y0BBABAB
Byetta Exenatide Endocrine System 693
Byetta 5micrograms/0.02ml inj 1.2ml pre-filled pens
0601023Y0BBAAAA
Byetta Exenatide Endocrine System 99
Bydureon 2mg inj vials
0601023Y0BCAAAC
Bydureon Exenatide Endocrine System 10
Exenatide 2mg inj vials
0601023Y0AAACAC
Exenatide Exenatide Endocrine System 1

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.